Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
25.10.23
/
50%
€30.80
Target price
25.10.24
€122.98
Performance (%)
61.04%
End price
26.10.24
€49.60
Summary
This prediction ended on 26.10.24 with a price of €49.60. With a performance of 61.04% the BUY prediction by Piper_Sandler was a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -5.376% | -5.376% | -51.913% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Piper Sandler from $135.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€35.20
17.03.25
17.03.25
€105.64
17.03.26
17.03.26
-46.59%
18.03.26
18.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
13.01.25
13.01.25
€137.24
13.01.26
13.01.26
-50.00%
14.01.26
14.01.26